Duodenal Neuroendocrine Tumor: a Diagnostic Surprise during Workup for Anemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neuroendocrine tumors (NETs) arising from the pancreas and duodenum together represent 18% of all gastroenteropancreatic NETs. Duodenal neuroendocrine tumor (D-NET) comprises 1%–3% of all primary duodenal tumors, of these only 20% are resectable. Surgery remains the only curative option provided a R0 resection can be done. We present a case of D-NET in an elderly male who was being investigated for anemia who was treated with pancreaticoduodenectomy and was discharged without sequele.
Abstract
Neuroendocrine tumors (NETs) arising from the pancreas and duodenum together represent 18% of all gastroenteropancreatic NETs. Duodenal neuroendocrine tumor (D-NET) comprises 1%–3% of all primary duodenal tumors, of these only 20% are resectable. Surgery remains the only curative option provided a R0 resection can be done. We present a case of D-NET in an elderly male who was being investigated for anemia who was treated with pancreaticoduodenectomy and was discharged without sequele.
참고문헌 (9)
- Yao JC, "One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States", J Clin Oncol, 26, pp.3063~3072 (2008)
- Hoffmann KM, "Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment", Best Pract Res Clin Gastroenterol, 19, pp.675~697 (2005)
- Modlin IM, "A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress", Am J Gastroenterol, 102, pp.1464~1473 (2007)
- Bilimoria KY, "Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years", Ann Surg, 249, pp.63~71 (2009)
- Eriksson B, "Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor", carcinoma, 2008, pp.87, 8~19
- DOTATOC multiphase PET, "CT and whole-body MRI", Cancer Imaging, 13, pp.63~72 (2013)
- Michelle Kang Kim, "Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors", Gut and Liver, 6(4), pp.405~410 (2012), 거트앤리버 소화기연관학회협의회
- Delle Fave G, "ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms", Neuroendocrinology, 103, pp.119~124 (2016)
- Barber TW, "The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable", Eur J Surg Oncol, 38, pp.64~71 (2012)